CombiGene AB announced that Peter Ekolind joins the Company September 27, 2022, when he assumes the position of Chief Operating Officer, initially as a part-time assignment. Peter Ekolind has extensive leadership experience from the pharmaceutical and medtech industries. Many years of work in a variety of positions have given Peter a good knowledge of product development, sales, marketing preclinical development and GMP manufacturing.

Peter has held several senior positions as, among other things, business area manager, COO and CEO. He has, in everything from large multi-international companies to small development companies, worked with business development, capitalization, internationalization, change management, innovation issues, public procurement, negotiation and research collaborations with universities and colleges.